Carbon Nanoparticles for use as a Vehicle to Target and Treat Macrophages, and Macrophage RNF41 as a Molecule Essential to Switch Macrophage Phenotype
Invention type: Technology
/
Case number: #22023
Researchers
Departments: Institute for Medical Engineering and Science
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living
-
methods and compositions to target and treat macrophages
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.